Study points out safety of probiotic strain
April 10, 2009
by Jeff Gelski
CLEVELAND — Researchers saw no harmful effects in rats that ate nearly 100,000 times the recommended dose for humans of Bacillus coagulans GBI-30, 6086, according to results of a study that will appear in the May issue of Food and Chemical Toxicology. Ganeden Biotech, Inc., Cleveland, markets B. coagulans GBI-30, 6086, a probiotic strain, under the brand name GanedenBC30.
"The results we saw with GanedenBC30 were off the charts compared to what we see with other common food ingredients and nutrients used to fortify foods," said Dr. John R. Endres, N.D., chief scientific officer of AIBMR Life Sciences, Puyallup, Wash., and one of the study’s authors.
The study sets the stage for more widespread incorporation of GanedenBC30 into foods, according to Ganeden Biotech.
""It was important to us to confirm the safety of consuming large amounts of GanedenBC30 since it may exist in several foods that might be consumed at the same time," said Sean Farmer, chief scientific officer for Ganeden Biotech. "But the results were not surprising given the historical consumption of GanedenBC30 by large populations of people over long periods of time with no adverse events."